In Part 1 of this two-part series on provider-supplier risk-sharing, we recapped the state of risk-sharing in 2019. If you missed it, here's the gist: Most providers are interested in these agreements because they push suppliers to take on more cost-quality performance risk and are an opportunity to improve clinical quality. Still, the pickup for these agreements has been slow as parties have been stymied by some formidable obstacles. More specifically, providers point to the challenges inherent in selecting metrics that are both measurable and meaningful, investing in requisite data extraction and analysis capabilities, and brokering a long-term partnership whose benefits are uncertain from the outset.